Cell Cryopreservation Market worth USD 19,381.6 million by 2033

The Market Statsville Group (MSG) publishes the new report on the "Cell Cryopreservation Market by Cryoprotectant Agents (Glycerol, Dimethyl Sulfoxide (DMSO), Others), by Process (Stem Cells, Oocytes and Embryos, Sperm, Others), by End-Use Industry (Pharmaceutical and Biotechnology Companies, Biobank, Others), and by Region (APAC, Europe, and Others) – Global Share and Forecast to 2033"

According to the Market Statsville Group (MSG), the global Cell Cryopreservation market size is expected to grow at a CAGR of 18.6% from 2023 to 2033.

Cryopreservation is a major element in the successful delivery of cell-based therapy. Cryopreservation is a major enabling technology in regenerative medicine that allows primary tissue isolates and components and prepared cell preparations to be stored for a prolonged period in a stable and safe atmosphere. This includes tissue and cell isolation, cryoprotection, cooling and freezing, frozen storage and transportation, thawing, and recovery, as well as other elements of the process that can be used for cell-based therapies. The purpose is to give clinical scientists a broad understanding of the benefits and disadvantages of cryopreservation in addition to helping them solve problems with daily work or consider future involvement in cryopreservation procedures. Slow freezing cryopreservation is the gold standard for cell culture preservation. However, the assumption that it is a widely utilized technique in fundamental research, the development of cell-based therapies, and the accuracy with which this procedure is carried out is boosting the market growth during the forecast period.

Adult stem cells (ASCs) are an important part of cell therapy research. ASCs can be derived from various sources, including bone marrow, peripheral blood, and adipose tissue, and thus hold tremendous potential due to their ability to develop into any type of human cell. Cell culture's growing popularity in developing drugs, cancer treatment, and vaccine manufacture has boosted funding for cell-based research. The US is a world leader in biological and medical science because of decades of research funding. The majority of the success may be attributable to public-private funding partners, such as state governments in developed economies, which have put money forward in the form of initiatives to attract cell research so that the states can gain from this promising technology. Pharmaceutical companies typically use private funds to fund trials to list their treatments. As the funding needed for cell-based research are so high, only a few developed countries, such as the US, have supported financing for these research. The NIH is the world's largest provider of biomedical research. Over 300,000 scientists work at universities, medical schools, and other research institutes in all 50 states, and over 83% of NIH funds are awarded through competitive grants.

Browse 131 market data Tables and 83 Figures spread through 258 Pages and in-depth TOC on Cell Cryopreservation Market By Cryoprotectant Agents, By Process, By End-User, By Region– Global Share and Forecast to 2033.

Global Cell Cryopreservation Market Segmentation

The overall cell cryopreservation market has been segmented into cryoprotectant agents, process, end-user, and region.

• By Cryoprotectant Agents (Glycerol, Dimethyl Sulfoxide (DMSO), and Others)
• By Process (Stem Cells, Oocytes and Embryos, Sperm, Semen, and Testicular Tissue, Hepatocytes, and Others)
• By End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Biobank, and Others (Hospitals, Specialized Centres))
• By Region (US, Canada, Mexico, UK, Germany, France, Italy, Spain, China, Japan, India, South Korea, Southeast Asia, Australia, Saudi Arabia, UAE, South Africa, Qatar, Nigeria, Israel, Brazil, Argentina, Peru)

Pharmaceuticals and Biotechnology segment is projected to witness the highest market share by end-user

Pharmaceuticals and biotechnology segment is expected to grow at the highest market share in 2022. The segment includes pharmaceutical and biotech companies that are involved in drug discovery, clinical trials, and research and development of advanced therapies. The growing demand for personalized medicines, the increasing number of clinical trials, and the rising prevalence of chronic diseases are driving the growth of the pharmaceuticals and biotechnology segment in the cell cryopreservation market. Cryopreservation is a critical process in the storage of cells for drug discovery, clinical trials, and regenerative medicine, and the demand for effective and reliable cell preservation solutions is increasing. Moreover, the increasing investment in developing new and advanced cryopreservation technologies, such as automated freezers and vitrification solutions, is further boosting the growth of the pharmaceuticals and biotechnology segment in the cell cryopreservation market.

Don't miss out on business opportunities in Cell Cryopreservation Market. Speak to our research analyst and gain crucial market insights that will benefit your business grow.

Asia Pacific is expected to showcase lucrative CAGR during the forecast period

Over the forecast period, the Asia Pacific market is expected to grow rapidly. The Asia Pacific region is poised to experience a surge in demand for cell cryopreservation in the upcoming years. This demand is expected to be fueled by various factors, including the region's large population base and increasing incidence of chronic diseases, leading to a growing need for regenerative medicine. The process of cryopreservation is critical for storing cells and tissues that can be used in regenerative medicine, making it an essential component of the market's growth in the region. Several government reports have highlighted the potential for growth in the cell cryopreservation market in the Asia Pacific region. For instance, the Japanese government has taken steps to promote the regenerative medicine industry, which is expected to fuel the growth of the cell cryopreservation market in the region.

This research report includes a study on the development and marketing strategies, along with a study on the product portfolios and winning strategies of the leading companies operating in the cell cryopreservation market. It also consists of the profiles of leading companies such as General Electric Company, Thermo Fisher Scientific Inc., Merck KGaA, AMS Biotechnology (Europe) Limited, BioLife Solutions Inc., HiMedia Laboratories Pvt. Ltd., Corning Incorporated, Cooper Companies, Inc., PromoCell GmbH, Planer PLC, Bio-Rad Laboratories India Pvt. Ltd, Miltenyi Biotec GmbH, Abcam plc., AMSBIO, Biogenuix, and Evia Bio. The key players' growing research and development activities for developing innovative drug solutions with are expected to drive market growth.

About Market Statsville Group

Market Statsville Group (MSG) is a business research and consulting platform of Statsville Consulting Private Limited, based in Oklahoma, USA. MSG is the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in market sizing, analysis, and intelligent business insights. MSG has experienced research analysts who are proficient at digging deep and providing various customizable data that help you make decisions with clarity, confidence, and impact. Furthermore, Market Statsville Group already benefited more than 1,000 companies each year for their revenue planning. It helped them take their disruptions/innovations early to the market by providing them research ahead of the curve.

MSG has an entire repository of research reports on more than 1,000 niche industries, 3,000 high-growth potentials markets, 5,000 data sets, and more than 12,000 company profiles.

Contact Us:

Market Statsville Group (MSG)

800 Third Avenue Suite A #1519

New York, US 10022

USA: +1 646-663-5829 | +91 702 496 8807

Email: sales@marketstatsville.com

Web: www.marketstatsville.com